Bloodwork results: 3 months on CJC-1295/Ipamorelin
Just got my latest labs back after 12 weeks on a standard CJC-1295/Ipamorelin protocol (100mcg/100mcg nightly). My IGF-1 levels moved from 145 ng/mL to 212 ng/mL, which is exactly where my doctor wanted them. I've definitely noticed better sleep quality and a bit more definition in my midsection, though the weight loss has been slow—only about 4 lbs down. My fasting glucose is stable at 88 mg/dL, so no issues there. I'm feeling great, but I'm wondering if anyone has experience adding AOD-9604 to this stack to help push through the final bit of stubborn fat? My doctor is open to it, but I want to hear if the synergy is worth the extra injection.
Congratulations on the progress. An increase in IGF-1 from 145 to 212 ng/mL suggests that your pituitary pulsatile release is responding well to the CJC/Ipamorelin stack, which is excellent. Regarding the slow weight loss, it is important to remember that these peptides primarily function by optimizing growth hormone production rather than acting as direct lipolytic agents like specific fat-loss peptides. Adding AOD-9604 is a common progression for many in the community. As a fragment of the GH molecule (tyrosine-177 through 191), AOD-9604 works differently by stimulating lipolysis and inhibiting lipogenesis without triggering the systemic IGF-1 spikes you see with your current protocol. Because you are already seeing stable glucose levels, adding AOD-9604 might help target those stubborn adipose stores more effectively without interfering with your current endocrine markers. Just monitor your site irritation, as AOD can be notorious for that. Keep tracking those labs, as they are your best compass for dosing adjustments.